Future Fields

Introducing Instar 1.0, our 6,000 square foot biofactory 🪰 Using fruit flies as sustainable bioreactors, Instar 1.0 will supply kilograms of recombinant proteins per year to meet increasing global demand. 🚀 Our co-founder and CEO gives a sneak peak of the impact and shares what this means for scientists developing the next generation of bioinnovations and medicine. 👇 Read the full story 👉 https://bit.ly/4fBPaKS

A team photo by the neon sign for milestones and special days is an FF tradition. 📸 From launching 5 proteins 🚀 to honouring women in science 👩🔬 to commemorating our Sustainability Committee 💚 to cheering on the Oilers 🏒 to sending one of our largest orders yet 📦 —we had lots to celebrate this year. 🎉 Happy holidays from Future Fields. ❤️ See you over by the neon sign in 2025!

DAC the halls 🎶🎄 our latest blog article speaks to Degrader Antibody Conjugates (DACs) and their potential in avoiding "on-target, off-site" toxicity in therapies. We illustrate this below 👇 Read more about this technology 👉 https://bit.ly/4iKY2jy

Getting cozy 🔥 PROTACs, or bi-functional degraders are used to “induce the proximity” of the protein target to E3 ligases. This enables ubiquitin to be added to the new target, leading to its degradation. Bi-functional degraders could change the game for patient health, as their catalytic mechanism provides large responses at low dosages compared to small molecule inhibitors. 👉 Read more about targeted protein degradation in our latest article: https://bit.ly/4f8RMiI

Jingle bells 🔔 growing cells 🧫 celebrating our last launch of the year! 🎉💜 Samples of sustainably made, fly-derived PDGF-BB are now available through our site. Request now to get yours in time before the holidays 🎄 👉 https://bit.ly/3BauJGs #PDGFBB #productlaunch

📢 PDGF-BB samples now available! 💜 This platelet-derived growth factor is expressed in our Drosophila-based EntoEngine™ and produced in our Green-certified lab. Our PDGF-BB is ready to support your research in bone grafting, tissue repair, angiogenesis, and beyond. From our lab to yours. 💌 Request a sample while quantities last! 👉 https://bit.ly/4iw89IU

Targeted Protein Degradation (TPD) is a rapidly evolving field with great potential for revolutionizing patient health. 🚀 Let's start with the basics. The fundamentals of protein degradation is the ubiquitin-proteasome system (UPS), illustrated below. 👇 Read more about TPD in our latest article 👉 https://bit.ly/3ZEhlDC

Happy flyday! 🪰 fun fly fact: we maintain stable lines of flies with the gene of interest with the help of balancer chromosomes. Watch the process below 🧬👇 Read more about leveraging genetic tools for recombinant protein expression 👉 https://bit.ly/3OKuO6N

Our Sustainability Committee delivered a presentation this week on the progress we made in 2024. 💚🌎♻️ Acting on the #climatecrisis is one our top company values, and we operationalize this with several projects on lab and office #sustainability. Some initiatives are small, incremental changes that we implement company-wide, such as proper waste sorting and turning off equipment when not in use. Other initiatives involve getting out into the community, such as our neighbourhood cleanups and clothing/food drives. We aren’t perfect, but we know that every climate action counts. Read more on our sustainability initiatives here 👉 https://bit.ly/3OHXqNY

Looking back on 2024, we gained invaluable learnings from leaders and collision spaces around the world. A notable space for us was the growing field of targeted protein degradation (TPD). What makes TPD and induced proximity different? What does it mean to “degrade” proteins, and why does it matter for patient health? We share our insights from two key conferences in our latest article 👇 https://bit.ly/4f2woLO